À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Öêʽ»áÉ磨×ܲ¿£º¶«¾©£¬CEO£ºÄÚÌÙÇç·ò£¬¡°À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¡±£©Ðû²¼£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾£¬Í¨¹ý¹ºÖùɷݺÍÈϹºµÚÈý·½·ÖÅäµÄÆÕͨ¹É£¬ÒÑÊÕ¹ºArteryex Inc.£¨×ܲ¿: ¶«¾©£¬CEO£ºLi Dongying£¬¡°Arteryex¡±£©¿¯ÐеĴó²¿ÃÅ¹É·Ý £¬ArteryexÊÇÒ»¼Ò¹æ»®ºÍ¿ª·¢ÓëÊý×Ö½â¾ö·½°¸Ïà¹ØµÄÈí¼þ¹«Ë¾£¬²¢ÓÚ2022Äê3ÔÂ31ÈÕ³ÉΪÆä×Ó¹«Ë¾¡£Á½¼Ò¹«Ë¾½«ºÏ×÷Ϊ»¼Õß¡¢Ò½ÁƱ£½¡×¨ÒµÈËÔ±ºÍÕû¸öÉç»á¿ª·¢ºÍÌṩÓë¸öÈ˽¡¿µ¼Ç¼£¨PHR£©Ïà¹ØµÄ·þÎñ¡£
À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÓÚ2021Äê4ÔÂÍƳöÁË¡°EWAY Future & Beyond¡±ÖÐÆÚÉÌÒµ¼Æ»®£¬½«ÊӽǴӻ¼ÕßµÄÊÓ½ÇתÒƵ½ÈËÃñ»òÿһλÏû·ÑÕß¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÒÔ¡°ÈÃÈËÃñʵÏÖ×î³äʵµÄÉú»î¡±ÎªÔ¸¾°£¬ÀûÓÃÈ˹¤ÖÇÄܵÈ×îÐÂÊý×Ö¼¼Êõ£¬ÎªÈËÃñÌṩҩƷºÍ½â¾ö·½°¸£¬Ö¼ÔÚÏû³ýÈËÃñµÄ½¹ÂÇ¡£
ArteryexÓµÓÐÓÅÐãµÄÈí¼þ¿ª·¢ÄÜÁ¦£¬¿ª·¢ÁË×Ô¼ºµÄPHRÏà¹Ø²úÎï·þÎñ£¬°üÂÞÓÃÓÚ´æ´¢ºÍת»»ÕýÔÚ½ÓÊÜÖÎÁÆ»¼Õß½¡¿µÏà¹ØÐÅÏ¢ºÍ´óÁ¿µÄÓû§Â¼ÈëÊý¾ÝµÄÓ¦Ó÷¨Ê½£¨APP£©ÒÔ¼°ÓÃÓÚ¹«Ë¾Ô±¹¤½¡¿µ¹ÜÀíµÄÓ¦Ó÷¨Ê½¡£
À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Ö¼ÔÚͨ¹ý×Ó¹«Ë¾ÊÕ¹º»ñµÃArteryexµÄ¿ª·¢ÄÜÁ¦ºÍÓÅÖʵÄPHR²úÎ´Ó¶ø¼ÓÇ¿ºÍ¿ìËÙÀ©Õ¹ÆäÊý×Ö½â¾ö·½°¸ÒµÎñ»ù´¡¡£³ýÁ˽Ӵ¥ÏÖÓвúÎïµÄпͻ§ÈºÌåÍ⣬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾»¹½«Í¨¹ýÀûÓÃArteryexµÄÊäÈë¼¼ÊõºÍͼÏñÊý¾Ýϵͳ£¬´Ù½ø¿ª·¢°üÂÞÐÂÓ¦ÓÃÔÚÄڵIJúÎï¡£´ËÍ⣬×÷ΪÕû¸öÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¼¯ÍÅ£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«Ìá¸ßͨ¹ýPHRÏà¹Ø²úÎï»ñµÃµÄÊý¾ÝÀûÓÃÂÊ£¬ÀûÓÃÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÔÚÆäÒ©ÎïµÞÔì»î¶¯ºÍ¼²²¡ÈÏÖª»î¶¯ÖÐÖÖÖÖʵ¼ù½øÒ»²½ÓÅ»¯Êý¾Ý¹ÜÀí¡£
ΪÁ˹¹½¨À´Àû¹ú¼Êw66¹Ù·½ÍøվͨÓÃƽ̨(EUP)£¬Í¨¹ýÕâЩ¾Ù´ë£¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«¼ÓÇ¿´´½¨Ò»À¿×Ó½â¾ö·½°¸£¬²¢¼Óǿά»¤ºÍÌá¸ß½¡¿µ¡¢Ô¤·ÀºÍ¼²²¡ÈÏÖªµÄ»ù´¡ÉèÊ©£¬²¢½«À©´ó¶ÔÈËÃñµÄТ¾´¡£
³ÉΪ×Ó¹«Ë¾ºó£¬ArteryexÏÖÈιÜÀíÍŶӽ«¼ÌÐø´æÔÚ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÊÕ¹ºArteryex×÷Ϊ×Ó¹«Ë¾²»»á¶ÔArteryexµÄºÏ²¢²ÆÕþÒµ¼¨·¢ÉúÖØ´óÓ°Ïì¡£
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120